“Altered Threonine Tyrosine Kinase (TTK) Expression Is Associated With Adverse Clinical Outcomes in Breast Tumors: An in Silico Approach”. Research, Society and Development 12, no. 13 (November 27, 2023): e40121344285. Accessed March 3, 2026. https://www.rsdjournal.org/rsd/article/view/44285.